Suppr超能文献

导致多发性骨髓瘤发展的突变过程。

Mutational processes contributing to the development of multiple myeloma.

机构信息

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.

Division of Molecular Pathology, The Institute of Cancer Research, London, UK.

出版信息

Blood Cancer J. 2019 Aug 6;9(8):60. doi: 10.1038/s41408-019-0221-9.

Abstract

To gain insight into multiple myeloma (MM) tumorigenesis, we analyzed the mutational signatures in 874 whole-exome and 850 whole-genome data from the CoMMpass Study. We identified that coding and non-coding regions are differentially dominated by distinct single-nucleotide variant (SNV) mutational signatures, as well as five de novo structural rearrangement signatures. Mutational signatures reflective of different principle mutational processes-aging, defective DNA repair, and apolipoprotein B editing complex (APOBEC)/activation-induced deaminase activity-characterize MM. These mutational signatures show evidence of subgroup specificity-APOBEC-attributed signatures associated with MAF translocation t(14;16) and t(14;20) MM; potentially DNA repair deficiency with t(11;14) and t(4;14); and aging with hyperdiploidy. Mutational signatures beyond that associated with APOBEC are independent of established prognostic markers and appear to have relevance to predicting high-risk MM.

摘要

为了深入了解多发性骨髓瘤(MM)的肿瘤发生机制,我们分析了 CoMMpass 研究中 874 个全外显子组和 850 个全基因组数据中的突变特征。我们发现编码和非编码区域分别由不同的单核苷酸变异(SNV)突变特征以及五个新出现的结构重排特征主导。反映不同主要突变过程——衰老、DNA 修复缺陷和载脂蛋白 B 编辑复合物(APOBEC)/激活诱导脱氨酶活性的突变特征表征了 MM。这些突变特征显示出亚组特异性的证据——与 MAF 易位 t(14;16)和 t(14;20) MM 相关的 APOBEC 归因的特征;可能与 t(11;14)和 t(4;14)相关的 DNA 修复缺陷;以及与超二倍体相关的衰老。与 APOBEC 相关的突变特征与既定的预后标志物无关,似乎与预测高危 MM 有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee90/6684612/eeb42fd251b5/41408_2019_221_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验